Nettis Eustachio, Foti Caterina, Ambrifi Marina, Baiardini Ilaria, Bianchi Leonardo, Borghi Alessandro, Caminati Marco, Canonica Giorgio Walter, Casciaro Marco, Colli Laura, Colombo Giselda, Corazza Monica, Cristaudo Antonio, De Feo Giulia, De Pita' Ornella, Di Gioacchino Mario, Di Leo Elisabetta, Fassio Filippo, Gangemi Sebastiano, Gatta Alessia, Hansel Katharina, Heffler Enrico, Incorvaia Cristoforo, Napolitano Maddalena, Patruno Cataldo, Peveri Silvia, Pigatto Paolo Daniele, Quecchia Cristina, Radice Anna, Ramirez Giuseppe Alvise, Romita Paolo, Rongioletti Franco, Rossi Oliviero, Savi Eleonora, Senna Gianenrico, Triggiani Massimo, Zucca Myriam, Maggi Enrico, Stingeni Luca
1Department of Emergency and Organ Transplantation, School and Chair of Allergology and Clinical Immunology, University of Bari - Aldo Moro, Bari, Italy.
2Department of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari, Bari, Italy.
Clin Mol Allergy. 2020 May 6;18:8. doi: 10.1186/s12948-020-00123-8. eCollection 2020.
Urticaria is a disorder affecting skin and mucosal tissues characterized by the occurrence of wheals, angioedema or both, the latter defining the urticaria-angioedema syndrome. It is estimated that 12-22% of the general population has suffered at least one subtype of urticaria during life, but only a small percentage (estimated at 7.6-16%) has acute urticaria, because it is usually self-limited and resolves spontaneously without requiring medical attention. This makes likely that its incidence is underestimated. The epidemiological data currently available on chronic urticaria in many cases are deeply discordant and not univocal, but a recent Italian study, based on the consultation of a national registry, reports a prevalence of chronic spontaneous urticaria of 0.02% to 0.4% and an incidence of 0.1-1.5 cases/1000 inhabitants/year.
We reviewed the recent international guidelines about urticaria and we described a methodologic approach based on classification, pathophysiology, impact on quality of life, diagnosis and prognosis, differential diagnosis and management of all the types of urticaria.
The aim of the present document from the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC) and the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA) is to provide updated information to all physicians involved in diagnosis and management of urticaria and angioedema.
荨麻疹是一种影响皮肤和黏膜组织的疾病,其特征为出现风团、血管性水肿或两者皆有,后者定义为荨麻疹 - 血管性水肿综合征。据估计,普通人群中12% - 22%的人在一生中至少患过一种荨麻疹亚型,但只有一小部分人(估计为7.6% - 16%)患有急性荨麻疹,因为它通常是自限性的,可自行消退,无需就医。这可能导致其发病率被低估。目前许多关于慢性荨麻疹的流行病学数据在很多情况下存在严重分歧且不明确,但最近一项基于意大利国家登记处咨询的研究报告称,慢性自发性荨麻疹的患病率为0.02%至0.4%,发病率为0.1 - 1.5例/1000居民/年。
我们回顾了近期关于荨麻疹的国际指南,并描述了一种基于所有类型荨麻疹的分类、病理生理学、对生活质量的影响、诊断与预后、鉴别诊断及管理的方法。
本文件由意大利变态反应学、哮喘与临床免疫学学会(SIAAIC)和意大利变态反应性、职业性与环境性皮肤病学会(SIDAPA)发布,旨在为所有参与荨麻疹和血管性水肿诊断与管理的医生提供最新信息。